Hyperspectral imaging of human liver allografts for prediction of initial graft function.
Early allograft dysfunction
Human
Hyperspectral imaging
Liver transplantation
Normothermic machine perfusion
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
14 Oct 2024
14 Oct 2024
Historique:
received:
31
05
2024
accepted:
30
09
2024
medline:
14
10
2024
pubmed:
14
10
2024
entrez:
14
10
2024
Statut:
epublish
Résumé
Ischemia reperfusion injury represents a significant yet difficult to assess risk factor for short- and long-term graft impairment in human liver transplantation (LT). As a non-invasive, non-ionizing tool, hyperspectral imaging (HSI) is capable of correlating optical properties with organ microperfusion. Hence, we here performed a study of human liver allografts assessed by HSI for microperfusion and prediction of initial graft function. Images of liver parenchyma of 37 human liver allografts were acquired at bench preparation, during normothermic machine perfusion (NMP), if applicable, and after reperfusion in the recipient. A specialized HSI acquisition software computed oxygen saturation (StO2), tissue hemoglobin indices (THI), near infrared perfusion indices (NIR), and tissue water indices (TWI). HSI parameters were analyzed for differences with regard to preservation technique, reperfusion sequence and presence of early allograft dysfunction (EAD). Organ preservation was performed by means of NMP (n = 31) or static cold storage (SCS; n = 6). Patients' demographics, donor characteristics, presence of EAD (NMP 36.7% vs. SCS 50%, p = 0.6582), and HSI parameters were comparable between both groups of preservation method. In organs developing EAD, NIR at 1, 2, and 4 h NMP and after reperfusion in the recipient was significantly lower (1 h NMP: 18.6 [8.6-27.6] vs. 28.3 [22.5-39.4], p = 0.0468; 2 h NMP: 19.4 [8.7-30.4] vs. 37.1 [27.5-44.6], p = 0.0011; 4 h NMP: 26.0 [6.8-37.1] vs. 40.3 [32.3-49.9], p = 0.0080; reperfusion: 13.0 [11.5-34.3] vs. 30.6 [19.3-44.0], p = 0.0212). HSI assessment of human liver allografts is feasible during organ preservation and in the recipient. NIR during NMP and after reperfusion might predict the onset of EAD. Larger trials are warranted for assessment of this novel technique in human LT.
Identifiants
pubmed: 39400566
doi: 10.1007/s00423-024-03497-4
pii: 10.1007/s00423-024-03497-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
306Informations de copyright
© 2024. The Author(s).
Références
MacConmara M, Hanish SI, Hwang CS, De Gregorio L, Desai DM, Feizpour CA, Tanriover B, Markmann JF, Zeh H 3rd, Vagefi PA (2020) Making every liver count: increased transplant yield of donor livers through normothermic machine perfusion. Ann Surg 272(3):397–401. https://doi.org/10.1097/SLA.0000000000004198
doi: 10.1097/SLA.0000000000004198
pubmed: 32694447
Mergental H, Laing RW, Kirkham AJ, Perera M, Boteon YL, Attard J, Barton D, Curbishley S, Wilkhu M, Neil DAH, Hubscher SG, Muiesan P, Isaac JR, Roberts KJ, Abradelo M, Schlegel A, Ferguson J, Cilliers H, Bion J, Adams DH, Morris C, Friend PJ, Yap C, Afford SC, Mirza DF (2020) Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nat Commun 11(1):2939. https://doi.org/10.1038/s41467-020-16251-3
doi: 10.1038/s41467-020-16251-3
pubmed: 32546694
pmcid: 7298000
Perera T, Mergental H, Stephenson B, Roll GR, Cilliers H, Liang R, Angelico R, Hubscher S, Neil DA, Reynolds G, Isaac J, Adams DA, Afford S, Mirza DF, Muiesan P (2016) First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion. Liver Transpl 22(1):120–124. https://doi.org/10.1002/lt.24369
doi: 10.1002/lt.24369
pubmed: 26566737
Sutton ME, op den Dries S, Karimian N, Weeder PD, de Boer MT, Wiersema-Buist J, Gouw AS, Leuvenink HG, Lisman T, Porte RJ (2014) Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS ONE 9(11):e110642. https://doi.org/10.1371/journal.pone.0110642
doi: 10.1371/journal.pone.0110642
pubmed: 25369327
pmcid: 4219693
Mergental H, Perera MT, Laing RW, Muiesan P, Isaac JR, Smith A, Stephenson BT, Cilliers H, Neil DA, Hubscher SG, Afford SC, Mirza DF (2016) Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am J Transpl 16(11):3235–3245. https://doi.org/10.1111/ajt.13875
doi: 10.1111/ajt.13875
Karimian N, Yeh H (2017) Opportunities for therapeutic intervention during machine perfusion. Curr Transpl Rep 4(2):141–148. https://doi.org/10.1007/s40472-017-0144-y
doi: 10.1007/s40472-017-0144-y
pubmed: 29109929
Ivanics T, Abreu P, De Martin E, Sapisochin G (2021) Changing trends in liver transplantation: challenges and solutions. Transplantation 105(4):743–756. https://doi.org/10.1097/TP.0000000000003454
doi: 10.1097/TP.0000000000003454
pubmed: 32910093
Deschenes M (2013) Early allograft dysfunction: causes, recognition, and management. Liver Transpl 19(Suppl 2):S6–8. https://doi.org/10.1002/lt.23746
doi: 10.1002/lt.23746
pubmed: 24038766
Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, Shaked A, Christie JD (2010) Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 16(8):943–949. https://doi.org/10.1002/lt.22091
doi: 10.1002/lt.22091
pubmed: 20677285
Agopian VG, Harlander-Locke MP, Markovic D, Dumronggittigule W, Xia V, Kaldas FM, Zarrinpar A, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW (2018) Evaluation of early allograft function using the liver graft assessment following transplantation risk score model. JAMA Surg 153(5):436–444. https://doi.org/10.1001/jamasurg.2017.5040
doi: 10.1001/jamasurg.2017.5040
pubmed: 29261831
Hoyer DP, Paul A, Gallinat A, Molmenti EP, Reinhardt R, Minor T, Saner FH, Canbay A, Treckmann JW, Sotiropoulos GC, Mathe Z (2015) Donor information based prediction of early allograft dysfunction and outcome in liver transplantation. Liver Int 35(1):156–163. https://doi.org/10.1111/liv.12443
doi: 10.1111/liv.12443
pubmed: 24351095
Romann S, Wagner T, Katou S, Reuter S, Vogel T, Becker F, Morgul H, Houben P, Wahl P, Pascher A, Radunz S (2022) Hyperspectral imaging for assessment of initial graft function in human kidney transplantation. Diagnostics (Basel) 12(5). https://doi.org/10.3390/diagnostics12051194
Sucher R, Wagner T, Kohler H, Sucher E, Guice H, Recknagel S, Lederer A, Hau HM, Rademacher S, Schneeberger S, Brandacher G, Gockel I, Seehofer D (2020) Hyperspectral imaging (HSI) of human kidney allografts. Ann Surg. https://doi.org/10.1097/SLA.0000000000004429
doi: 10.1097/SLA.0000000000004429
pubmed: 33196483
Fodor M, Lanser L, Hofmann J, Otarashvili G, Puhringer M, Cardini B, Oberhuber R, Resch T, Weissenbacher A, Maglione M, Margreiter C, Zelger P, Pallua JD, Ofner D, Sucher R, Hautz T, Schneeberger S (2022) Hyperspectral imaging as a tool for viability assessment during normothermic machine perfusion of human livers: a proof of concept pilot study. Transpl Int 35:10355. https://doi.org/10.3389/ti.2022.10355
doi: 10.3389/ti.2022.10355
pubmed: 35651880
pmcid: 9150258
Holmer A, Marotz J, Wahl P, Dau M, Kammerer PW (2018) Hyperspectral imaging in perfusion and wound diagnostics - methods and algorithms for the determination of tissue parameters. Biomed Tech (Berl) 63(5):547–556. https://doi.org/10.1515/bmt-2017-0155
doi: 10.1515/bmt-2017-0155
pubmed: 30028724
Kneifel F, Wagner T, Flammang I, Vogt F, Katou S, Vogel T, Houben P, Becker F, Wahl P, Pascher A, Radunz S (2022) Hyperspectral imaging for viability assessment of human liver allografts during normothermic machine perfusion. Transpl Direct 8(12):e1420. https://doi.org/10.1097/TXD.0000000000001420
doi: 10.1097/TXD.0000000000001420
Lu G, Fei B (2014) Medical hyperspectral imaging: a review. J Biomed Opt 19(1):10901. https://doi.org/10.1117/1.JBO.19.1.010901
doi: 10.1117/1.JBO.19.1.010901
pubmed: 24441941
Belghiti J, Panis Y, Sauvanet A, Gayet B, Fekete F (1992) A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet 175(3):270–272
pubmed: 1514163
Zarrinpar A, Busuttil RW (2013) Liver transplantation: past, present and future. Nat Rev Gastroenterol Hepatol 10(7):434–440. https://doi.org/10.1038/nrgastro.2013.88
doi: 10.1038/nrgastro.2013.88
pubmed: 23752825
Ince C (2015) Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care 19 Suppl 3 (Suppl 3):S8. https://doi.org/10.1186/cc14726
Pulitano C, Joseph D, Sandroussi C, Verran D, Ho P, Debiasio A, Luongo A, McCaughan GW, Shackel NA, Crawford M (2017) Postreperfusion microcirculatory derangements after liver transplantation: relationship to hemodynamics, serum mediators, and outcome. Liver Transpl 23(4):527–536. https://doi.org/10.1002/lt.24721
doi: 10.1002/lt.24721
pubmed: 28073175
Nasralla D, Coussios CC, Mergental H, Akhtar MZ, Butler AJ, Ceresa CDL, Chiocchia V, Dutton SJ, Garcia-Valdecasas JC, Heaton N, Imber C, Jassem W, Jochmans I, Karani J, Knight SR, Kocabayoglu P, Malago M, Mirza D, Morris PJ, Pallan A, Paul A, Pavel M, Perera M, Pirenne J, Ravikumar R, Russell L, Upponi S, Watson CJE, Weissenbacher A, Ploeg RJ, Friend PJ, Consortium for Organ Preservation in E (2018) A randomized trial of normothermic preservation in liver transplantation. Nature 557(7703):50–56. https://doi.org/10.1038/s41586-018-0047-9
doi: 10.1038/s41586-018-0047-9
pubmed: 29670285
Allard MA, Castro-Benitez C, Imai K, Selten J, Lopez A, Sebagh M, Lemoine A, Sa Cunha A, Cherqui D, Castaing D, Vibert E, Adam R (2018) Suitability of livers for transplantation when treated by normothermic machine perfusion. Clin Transpl 32(6):e13256. https://doi.org/10.1111/ctr.13256
doi: 10.1111/ctr.13256
Vogel T, Brockmann JG, Quaglia A, Morovat A, Jassem W, Heaton ND, Coussios CC, Friend PJ (2017) The 24-hour normothermic machine perfusion of discarded human liver grafts. Liver Transpl 23(2):207–220. https://doi.org/10.1002/lt.24672
doi: 10.1002/lt.24672
pubmed: 27809409
Durand F, Renz JF, Alkofer B, Burra P, Clavien PA, Porte RJ, Freeman RB, Belghiti J (2008) Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 14(12):1694–1707. https://doi.org/10.1002/lt.21668
doi: 10.1002/lt.21668
pubmed: 19025925
Adam R, Karam V, Cailliez V, JG OG, Mirza D, Cherqui D, Klempnauer J, Salizzoni M, Pratschke J, Jamieson N, Hidalgo E, Paul A, Andujar RL, Lerut J, Fisher L, Boudjema K, Fondevila C, Soubrane O, Bachellier P, Pinna AD, Berlakovich G, Bennet W, Pinzani M, Schemmer P, Zieniewicz K, Romero CJ, De Simone P, Ericzon BG, Schneeberger S, Wigmore SJ, Prous JF, Colledan M, Porte RJ, Yilmaz S, Azoulay D, Pirenne J, Line PD, Trunecka P, Navarro F, Lopez AV, De Carlis L, Pena SR, Kochs E, Duvoux C, all the other 126 contributing c, the European L, Intestine, Transplant A (2018) 2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50-year evolution of liver transplantation. Transpl Int 31 (12):1293–1317. https://doi.org/10.1111/tri.13358
Benko T, Belker J, Gallinat A, Treckmann JW, Paul A, Minor T, Hoyer DP (2019) Analysis of data from the oxygen persufflation in liver transplantation (OPAL) study to determine the role of factors affecting the hepatic microcirculation and early allograft dysfunction. Ann Transpl 24:481–488. https://doi.org/10.12659/AOT.915214
doi: 10.12659/AOT.915214
Jansen-Winkeln B, Holfert N, Kohler H, Moulla Y, Takoh JP, Rabe SM, Mehdorn M, Barberio M, Chalopin C, Neumuth T, Gockel I (2019) Determination of the transection margin during colorectal resection with hyperspectral imaging (HSI). Int J Colorectal Dis 34(4):731–739. https://doi.org/10.1007/s00384-019-03250-0
doi: 10.1007/s00384-019-03250-0
pubmed: 30712079
Mehdorn M, Kohler H, Rabe SM, Niebisch S, Lyros O, Chalopin C, Gockel I, Jansen-Winkeln B (2020) Hyperspectral imaging (HSI) in acute mesenteric ischemia to detect intestinal perfusion deficits. J Surg Res 254:7–15. https://doi.org/10.1016/j.jss.2020.04.001
doi: 10.1016/j.jss.2020.04.001
pubmed: 32402834
Wagner T, Radunz S, Becker F, Chalopin C, Kohler H, Gockel I, Jansen-Winkeln B (2022) Hyperspectral imaging detects perfusion and oxygenation differences between stapled and hand-sewn intestinal anastomoses. Innov Surg Sci 7(2):59–63. https://doi.org/10.1515/iss-2022-0007
doi: 10.1515/iss-2022-0007
pubmed: 36317013
pmcid: 9574651
Wagner T, Katou S, Wahl P, Vogt F, Kneifel F, Morgul H, Vogel T, Houben P, Becker F, Struecker B, Pascher A, Radunz S (2022) Hyperspectral imaging for quantitative assessment of hepatic steatosis in human liver allografts. Clin Transpl 36(8):e14736. https://doi.org/10.1111/ctr.14736
doi: 10.1111/ctr.14736
Chen S, Wang T, Luo T, He S, Huang C, Jia Z, Zhan L, Wang D, Zhu X, Guo Z, He X (2021) Prediction of graft survival post-liver transplantation by L-GrAFT risk score model, EASE score, MEAF scoring, and EAD. Front Surg 8:753056. https://doi.org/10.3389/fsurg.2021.753056
doi: 10.3389/fsurg.2021.753056
pubmed: 34869560
pmcid: 8641658
Jochmans I, Fieuws S, Monbaliu D, Pirenne J (2017) Model for early allograft function outperforms early allograft dysfunction as a predictor of transplant survival. Transplantation 101(8):e258–e264. https://doi.org/10.1097/TP.0000000000001833
doi: 10.1097/TP.0000000000001833
pubmed: 28557956
Luo T, He SJ, Chen SR, Wang TL, Huang CJ, Wang DP, Ju WQ, Zhao Q, Chen MG, Chen YH, Hu AB, Ma Y, Wang GD, Zhu XF, Huang SW, Guo ZY, He XS (2021) Prediction of post-transplant graft survival by different definitions of early allograft dysfunction. Ann Palliat Med 10(8):8584–8595. https://doi.org/10.21037/apm-21-1012
doi: 10.21037/apm-21-1012
pubmed: 34379984
Agopian VG, Markovic D, Klintmalm GB, Saracino G, Chapman WC, Vachharajani N, Florman SS, Tabrizian P, Haydel B, Nasralla D, Friend PJ, Boteon YL, Ploeg R, Harlander-Locke MP, Xia V, DiNorcia J, Kaldas FM, Yersiz H, Farmer DG, Busuttil RW (2021) Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction. J Hepatol 74(4):881–892. https://doi.org/10.1016/j.jhep.2020.09.015
doi: 10.1016/j.jhep.2020.09.015
pubmed: 32976864